Oral versus parenteral antimicrobials for the treatment of cellulitis: A randomized non-inferiority trial

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 2, 2015, Pages 581-586

  Aboltins, Craig A ^a,b   Hutchinson, Anastasia F ^a,c   Sinnappu, Rabindra N ^a   Cresp, Damian ^a   Risteski, Chrissie ^a   Kathirgamanathan, Rajasutharsan ^a   Tacey, Mark A ^a,b   Chiu, Herman ^a   Lim, Kwang ^a,b  

^a NORTHERN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

Antimicrobial agents; Drug therapy; Oral administration; Parenteral infusions; Randomized controlled trials

Indexed keywords

CEFALEXIN; CEFAZOLIN; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CELLULITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DRUG TREATMENT FAILURE; FEMALE; HUMAN; INDIGESTION; INJECTION SITE PAIN; INTENTION TO TREAT ANALYSIS; MALE; NAUSEA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT SATISFACTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; THRUSH; AGED; CLINICAL TRIAL; INFUSION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFECTIVE AGENTS; CELLULITIS; FEMALE; HUMANS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84922455791     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku397     Document Type: Article

References (13)

1. Jorup-Ronstrom C, Britton S, Gavlevik A et al. The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas. Infection 1984; 12: 390-4.
2. Bernard P, Chosidow O, Vaillant L. Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial. BMJ 2002; 325: 864.
3. Kilburn SA, Featherstone P, Higgins B et al. Interventions for cellulitis and erysipelas. Cochrane Database Syst Rev 2010; issue 6: CD004299.
4. Antibiotic Expert Group. Cellulitis and Erysipelas. In: Therapeutic Guidelines: Antibiotic. Version 14. Melbourne: Therapeutic Guidelines Limited, 2010.
5. Corwin P, Toop L, McGeoch G et al. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ 2005; 330: 129.
6. Garrett T, Harbort Y, Trebble M et al. Once or twice-daily, algorithmbased intravenous cefazolin for home-based cellulitis treatment. Emerg Med Australas 2012; 24: 383-92.
7. Talbot GH, Powers JH, Fleming TR et al. Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update fromthe Biomarkers Consortium of the Foundation for the National Institutes of Health. Clin Infect Dis 2012; 55: 1114-21.
8. Grayson ML, McDonald M, Gibson K et al. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults. Clin Infect Dis 2002; 34: 1440-8.
9. Bernard P, Plantin P, Roger H et al. Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study. Br J Dermatol 1992; 127: 155-9.
10. Pertel PE, Eisenstein BI, Link AS et al. The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas. Int J Clin Pract 2009; 63: 368-75.
11. Leman P, Mukherjee D. Flucloxacillin alone or combined with benzylpenicillin to treat lower limb cellulitis: a randomised controlled trial. Emerg Med J 2005; 22: 342-6.
12. Corey GR, Wilcox M, Talbot GH et al. Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clin Infect Dis 2010; 51: 641-50.
13. National Institute for Health and Care Excellence. Cellulitis-Acute- Clinical Knowledge Summary. London: National Institute for Health and Care, 2012. http://cks.nice.org.uk/cellulitis-acute.